TANDEM AUTOLOGOUS AND NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FROM HLA-MATCHED RELATED OR UNRELATED DONORS FOR ADVANCED LYMPHOMA OR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

被引：2
|
作者：
Sorror, M. L. [1 ,2 ]
Storer, B. [1 ,2 ]
Sandmaier, B. M. [1 ,2 ]
Chauncey, T. [1 ,2 ,3 ]
Storb, R. F. [1 ,2 ]
Maloney, D. G. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] VA Puget Sound Hlth Care Syst, Seattle, WA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
178
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Sequential Autologous Followed by Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors Improves Outcomes of Patients (pts) with Bulky Lymphoma or Chronic Lymphocytic Leukemia (CLL)
    Sorror, Mohamed L.
    Storer, Bany
    Sandmaier, Brenda M.
    Chauncey, Thomas
    Maris, Michael T.
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2010, 116 (21) : 979 - 979
  • [2] Nonmyeloablative conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related or unrelated donors for chemotherapy-refractory chronic lymphocytic leukemia (CLL).
    Sorror, M
    Maris, M
    Storer, B
    Sandmaier, B
    Stuart, M
    Hegenbart, U
    Agura, E
    Chauncey, T
    Leis, J
    Pulsipher, M
    McSweeney, P
    Radich, J
    Wade, J
    Bruno, B
    Langston, A
    Niederwieser, D
    Blume, K
    Storb, R
    Maloney, D
    BLOOD, 2004, 104 (11) : 639A - 639A
  • [3] Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors.
    Sorror, Mohamed L.
    Storer, Barry
    Sandmaier, Brenda M.
    Franke, Georg N.
    Laport, Ginna G.
    Chauncey, Thomas
    Agura, Edward
    Maris, Michael T.
    Wade, James
    Pulsipher, Michael A.
    Maziarz, Richard T.
    Sahebi, Firoozeh
    McSweeney, Peter
    Bruno, Benedetto
    Vindelov, Lars
    Yeager, Andrew M.
    Rezvani, Andrew
    Niederwieser, Dietger W.
    Blume, Karl G.
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2010, 116 (21) : 553 - 553
  • [4] Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)
    Sorror, ML
    Maris, MB
    Sandmaier, BM
    Jain-Stuart, M
    Storer, B
    Hegenbart, U
    McSweeney, P
    Chauncey, T
    Bruno, B
    Wade, J
    Agura, E
    Pulsipher, M
    Leis, J
    Little, MT
    Niederwieser, D
    Blume, K
    Storb, R
    Maloney, DG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 26 - 26
  • [5] Nonmyeloablative (NM) conditioning and allogeneic hematopoietic cell transplantation (HCT) with HLA-matched unrelated donor (URD) for patients (Pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL).
    Sorror, ML
    Maris, M
    Storer, B
    Sandmaier, BM
    Maloney, DG
    Stuart, MJ
    Pulsipher, M
    McSweeney, PA
    Leis, JF
    Wade, JC
    Blume, KG
    Storb, RF
    BLOOD, 2003, 102 (11) : 482A - 482A
  • [6] Comparison of allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning with HLA-matched related (MRD), unrelated (URD), and related haploidentical (Haplo) donors for relapsed or refractory Hodgkin lymphoma (HL)
    Burroughs, Lauri
    O'Donnell, Paul
    Sandmaier, Brenda M.
    Storer, Barry
    Luznik, Leo
    Symons, Heather
    Maris, Michael
    Blume, Karl G.
    Niederwieser, Dietger W.
    Bruno, Benedetto
    Maziarz, Richard T.
    Pulsipher, Michael
    Petersen, Finn
    McSwceney, Peter A.
    Chauncey, Thomas
    Agura, Edward
    Wade, James C.
    Storb, Rainer F.
    Fuchs, Ephraim J.
    Maloney, David G.
    BLOOD, 2007, 110 (11) : 58A - 59A
  • [7] Infection-related mortality after allogeneic hematopoietic cell transplantation from HLA-matched related and unrelated donors
    Yamasaki, S
    Fukuda, T
    Kim, SW
    Mori, SI
    Tanosaki, R
    Taniguchi, S
    Takaue, Y
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 47 - 47
  • [8] HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia
    Baron, F
    Maris, MB
    Storer, BE
    Sandmaier, BM
    Stuart, MJ
    McSweeney, PA
    Radich, JP
    Pulsipbek, MA
    Agura, ED
    Chauncey, TR
    Maloney, DG
    Shizuru, JA
    Storb, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (04) : 272 - 279
  • [9] Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia: Comparison of Outcomes Among HLA-Matched Sibling Donors, HLA-Matched Unrelated Donors and HLA-Mismatched Family Donors
    Yu, Sijian
    Sun, Jing
    Fan, Zhiping
    Zhang, Yu
    Jiang, Qianli
    Huang, Fen
    Dai, Min
    Zhou, Hongsheng
    Xu, Dan
    Wei, Yongqiang
    Xuan, Li
    Liu, Qifa
    BLOOD, 2014, 124 (21)
  • [10] Longer follow up of patients (PTS) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)
    Sorror, M. L.
    Storer, B.
    Sandmaier, B. M.
    Maris, M. B.
    Shizuru, J.
    Niederwieser, D.
    Agura, E.
    Chauncey, T.
    Maziarz, R.
    Pulsipher, M.
    McSweeney, P.
    Wade, J.
    Bruno, B.
    Langston, A.
    Blume, K.
    Storb, R.
    Maloney, D. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 133 - 134
12345